The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Health & life sciences - Major diseases
Tick (check) box to add article to PDF "basket"
Active rehabilitation has emerged as a powerful tool in cancer care. However, its full potential to help restore survivors' functional capacity, boost their quality of life and possibly even reduce the risk of recurrence has yet to be tapped. EU-funded researchers are looking into e-health solutions to take the technique another step further.
Published: 25 May 2018
EU-funded researchers are using the latest vaccine technologies and antigen discovery tools to develop a multi-stage, multi-antigen vaccine against Plasmodium falciparum, the parasite responsible for the deadliest form of malaria.
Published: 25 April 2018
Hundreds of millions of people each year are infected with Plasmodium vivax, the most widespread form of malaria worldwide. An EU-funded project is tackling the mosquito-borne parasite, leading cutting-edge research efforts to accelerate the development of effective vaccines.
Published: 25 April 2018
Using innovative nanotechnologies, an EU-funded project is developing more efficient and sustainable vaccine manufacturing processes. The cost of vaccines puts a brake on wider immunisation, so these new processes will find broad application - especially in developing economies.
Published: 19 February 2018
EU-funded researchers have developed a carbon with tiny pores that could prevent infection of livers by intestinal bacteria - a common complication in chronic liver disease. The material could improve patients' quality of life and chances of survival, while reducing the use of antibiotics in managing the disease.
Published: 17 November 2017
Many people suffering from curable secondary hypertension - high blood pressure that is the result of a condition - are incorrectly diagnosed, so they don't receive the treatment they need. An EU-funded project's research aims to lead to a blood test that aids diagnosis and improves treatment.
Published: 9 November 2017
An EU-funded project is carrying out the first clinical trial among elderly cardiac patients of a novel multi-medication pill to prevent recurrent heart attacks, improve the efficacy of care and save lives.
Published: 27 September 2017
EU and industry-funded researchers have developed a portable device to test in the field whether a person has caught the deadly Ebola disease. It gives reliable results in 75 minutes, which can help contain outbreaks and save lives.
Published: 18 September 2017
EU-funded project ULTRAPLACAD is developing a low-cost device that can detect the early signs of cancer by analysing blood. The device would allow doctors to screen more patients and provide treatment at an earlier stage of the disease - helping to save lives.
Published: 16 September 2016
Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) brings together leading HIV researchers from public organisations and biotech companies from across the world in a focused effort to develop protective and therapeutic HIV vaccines.The EAVI2020 consortium unites scientists from 22 institutions, pooling their knowledge and expertise to develop novel candidate vaccines that can be taken through to human trials within five years.
Published: 2 March 2016